Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Business Officer

Chief Financial Officer

Chief Scientific Officer

President and CEO

Chief Legal Officer

Chief Medical Officer

VP of Finance and Controller

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapi...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-20	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-02-20	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-20	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-02-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-20	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-06	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-06-08	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-03-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-01-19	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-12-02	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-10-06	Premium	sold	Premium	Premium	Premium	VP of Finance and Controller
2022-10-06	Premium	acquired	Premium	Premium	Premium	VP of Finance and Controller
2022-09-15	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2022-08-25	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-08-25	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-08-22	Premium	acquired	Premium	Premium	Premium	VP of Finance and Controller
2022-05-13	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-05-09	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-05-05	Premium	acquired	Premium	Premium	Premium	VP of Finance and Controller
2022-03-15	Premium	acquired	Premium	Premium	Premium	VP of Finance and Controller
2022-03-04	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-02-08	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-01-26	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-01-25	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

CRBU - Caribou Biosciences, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for CRBU